MarginsXMarginsX
Home › Markets › Health Care › GUTS

Fractyl Health Inc. (GUTS)

GUTS trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$0.9918
+9.76% on the day
Market cap
$13.2M
Nano cap
Revenue · 2025
$0
-100.0% on 2024
Net income · 2025
-$141.0M

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1572616/000119312526121793/0001193125-26-121793-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerGUTS on Nasdaq
SectorHealth Care
IndustryMedical/Dental Instruments
CountryUnited States
IPO year2024
SEC CIK0001572616
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inDE

Financials · 2025

LineValue
Revenue$0
Net income-$141.0M
Operating income-$96.8M
Net marginNeeds revenue and net income
Operating marginOperating income not reported
Revenue growth-100.0%
Cash$81.5M
Total assets$121.4M
P/E (computed)Net income was not positive
P/S (computed)Needs market cap and revenue

Warning signs

Cash runway
5.0 months
$31.5M cash at September 30, 2026
Share count, 1 year
+16.2%
2025-10-31 to 2026-11-02
Going-concern doubt
Yes
10-Q filed November 12, 2026
Insider net buying, 12 months
$187K
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"Management intends to mitigate the conditions and events that raise substantial doubt about the Company's ability to continue as a going concern entity by (i) negotiating other cash equity, debt or strategic financing, (ii) continuing to pursue the necessary regulatory approvals to launch commercially in the U.S. market, (iii) executing cost-cutting measures to manage operating cash spending, including the workforce "
10-Q 2026-11-12
Cash and burn$31.5M cash; operating cash flow -$18.9M a quarter.Report 2026-09-30
Shares outstanding13,264,926 (2026-11-02); 137,044,440 a year earlier. 1y figure adjusted for split (1-for-12 overall).Cover page 2026-11-02
Reverse splits, 3 years1; latest 1-for-12 on 2026-10-05Source 2026-10-05
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 months2 (8-K item 3.01)8-K 2026-09-11
AuditorErnst & Young LLP, Boston, Massachusetts, United StatesPCAOB Form AP 2026-04-06
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $187K, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
Not filed-$14.2M-$15.7M$31.5M$413KNeeds four quarters10-Q 2026-11-12
Q2 2026
2026-06-30
Not filed-$25.5M-$15.9M$47.1MNo debt tagsNeeds four quarters10-Q 2026-11-12
Q1 2026
2026-03-31
Not filed$9.2M-$22.5M$63.2MNo debt tagsNeeds four quarters10-Q 2026-11-12
Q4 2025
2025-12-31
Not filed-$43.7M-$21.3M$81.5M$0$010-K 2026-03-24
Q3 2025
2025-09-30
Not filed-$45.6M-$22.7M$77.7MNo debt tagsNeeds four quarters10-Q 2026-11-12
Q2 2025
2025-06-30
Not filed-$27.9M-$21.2M$22.3MNo debt tagsNeeds four quarters10-Q 2026-11-12
Q1 2025
2025-03-31
Not filed-$23.7M-$25.1M$42.1MNo debt tagsNeeds four quarters10-Q 2026-11-12
Q4 2024
2024-12-31
$3K-$25.0M-$17.0M$67.5MNo debt tags$93K10-K 2026-03-24

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52025-09-26
Latest annual report10-K2026-03-24
Latest quarterly / interim10-Q2026-11-12
Latest current report8-K2026-11-12
Latest proxyDEF 14A2026-08-24

Source: SEC EDGAR submissions feed, 232 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-2.8%
1 month-77.5%
3 months-88.6%
Year to date-96.6%
1 year-93.3%
From 52-week high-96.8%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
DRIODarioHealth Corp.$1.15-8.73%$13.0M
PAVMPAVmed Inc.$1.75+7.36%$14.0M
CTSOCytosorbents Corporation$4.85-0.41%$15.3M
SNWVSANUWAVE Health Inc.$1.81-0.55%$15.6M
FEMYFemasys Inc.$1.28-8.57%$11.1M
RVPRetractable Technologies Inc.$0.5600+0.02%$16.8M
SINTSiNtx Technologies Inc.$1.34-1.11%$10.1M
CVRXCVRx Inc.$0.6130+0.92%$17.5M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier